These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102. The impact of ductal carcinoma in situ on health services utilization. Paszat L; Sutradhar R; Rakovitch E Breast Cancer Res Treat; 2020 Jul; 182(1):159-168. PubMed ID: 32385793 [TBL] [Abstract][Full Text] [Related]
103. Non-surgical treatment for ductal carcinoma in situ of the breasts - a prospective study on patient's perspective. Co M; Lee A; Kwong A Cancer Treat Res Commun; 2021; 26():100241. PubMed ID: 33340904 [TBL] [Abstract][Full Text] [Related]
104. Oncological safety of active surveillance for low-risk ductal carcinoma in situ - a systematic review and meta-analysis. Davey MG; Lowery AJ; Kerin MJ Ir J Med Sci; 2023 Aug; 192(4):1595-1600. PubMed ID: 36112315 [TBL] [Abstract][Full Text] [Related]
105. Low-grade screen-detected ductal carcinoma in situ progresses more slowly than high-grade lesions: evidence from an international multi-centre study. Ponti A; Ronco G; Lynge E; Tomatis M; Anttila A; Ascunce N; Broeders M; Bulliard JL; Castellano I; Fitzpatrick P; Frigerio A; Hofvind S; Májek O; Segnan N; Taplin S; Breast Cancer Res Treat; 2019 Oct; 177(3):761-765. PubMed ID: 31250357 [TBL] [Abstract][Full Text] [Related]
106. Factors Associated With Underestimation of Invasive Cancer in Patients With Ductal Carcinoma In Situ: Precautions for Active Surveillance. Chavez de Paz Villanueva C; Bonev V; Senthil M; Solomon N; Reeves ME; Garberoglio CA; Namm JP; Lum SS JAMA Surg; 2017 Nov; 152(11):1007-1014. PubMed ID: 28700803 [TBL] [Abstract][Full Text] [Related]
107. Mortality of women with ductal carcinoma in situ of the breast: a population-based study from the Girona province, Spain (1994-2013). Roca-Barceló A; Viñas G; Pla H; Carbó A; Comas R; Izquierdo Á; Pinheiro PS; Vilardell L; Solans M; Marcos-Gragera R Clin Transl Oncol; 2019 Jul; 21(7):891-899. PubMed ID: 30536209 [TBL] [Abstract][Full Text] [Related]
108. The shifting nature of women's experiences and perceptions of ductal carcinoma in situ. Kennedy F; Harcourt D; Rumsey N J Adv Nurs; 2012 Apr; 68(4):856-67. PubMed ID: 21790736 [TBL] [Abstract][Full Text] [Related]
109. Racial differences in breast cancer, cardiovascular disease, and all-cause mortality among women with ductal carcinoma in situ of the breast. Berkman A; F Cole B; Ades PA; Dickey S; Higgins ST; Trentham-Dietz A; Sprague BL; Lakoski SG Breast Cancer Res Treat; 2014 Nov; 148(2):407-13. PubMed ID: 25326349 [TBL] [Abstract][Full Text] [Related]
110. Treatment Patterns in Women Age 80 and Over With DCIS: A Report From the National Cancer Database. Frebault J; Bergom C; Cortina CS; Shukla ME; Zhang Y; Huang CC; Kong AL Clin Breast Cancer; 2022 Aug; 22(6):547-552. PubMed ID: 35595612 [TBL] [Abstract][Full Text] [Related]
111. Large and diffuse ductal carcinoma in situ: potentially lethal subtypes of "preinvasive" disease. O'Keefe TJ; Harismendy O; Wallace AM Int J Clin Oncol; 2022 Jan; 27(1):121-130. PubMed ID: 34618239 [TBL] [Abstract][Full Text] [Related]
112. Relationship between number of breast cancer operations performed and 5-year survival after treatment for early-stage breast cancer. Gilligan MA; Neuner J; Zhang X; Sparapani R; Laud PW; Nattinger AB Am J Public Health; 2007 Mar; 97(3):539-44. PubMed ID: 17267725 [TBL] [Abstract][Full Text] [Related]
113. Ductal carcinoma in situ in African American versus Caucasian American women: analysis of clinicopathologic features and outcome. Nassar H; Sharafaldeen B; Visvanathan K; Visscher D Cancer; 2009 Jul; 115(14):3181-8. PubMed ID: 19452544 [TBL] [Abstract][Full Text] [Related]
114. Severe fatigue after treatment of ductal carcinoma in situ: A comparison with age-matched breast cancer survivors and healthy controls. Abrahams HJG; Smits L; Lugt M; Roos WK; Kamm Y; Heins MJ; Verhagen CAHHVM; Gielissen MFM; Knoop H Breast; 2017 Feb; 31():76-81. PubMed ID: 27816835 [TBL] [Abstract][Full Text] [Related]
115. Analysis of active surveillance as a treatment modality in ductal carcinoma in situ. Fan B; Pardo JA; Alapati A; Hopewood P; Mohammad Virk Z; James TA Breast J; 2020 Jun; 26(6):1221-1226. PubMed ID: 31925857 [TBL] [Abstract][Full Text] [Related]
116. Outcomes of Active Surveillance for Ductal Carcinoma in Situ: A Computational Risk Analysis. Ryser MD; Worni M; Turner EL; Marks JR; Durrett R; Hwang ES J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26683405 [TBL] [Abstract][Full Text] [Related]
117. Timing of Breast Cancer Surgery-How Much Does It Matter? Mansfield SA; Abdel-Rasoul M; Terando AM; Agnese DM Breast J; 2017 Jul; 23(4):444-451. PubMed ID: 28117507 [TBL] [Abstract][Full Text] [Related]
118. Saving the Breast Saves the Lives of Breast Cancer Patients. Akbari ME; Khayamzadeh M; Mirzaei HR; Moradi A; Akbari A; Moradian F; Khalili N Int J Surg Oncol; 2020; 2020():8709231. PubMed ID: 32181017 [TBL] [Abstract][Full Text] [Related]
119. The impact of patient characteristics and lifestyle factors on the risk of an ipsilateral event after a primary DCIS: A systematic review. Alaeikhanehshir S; Engelhardt EG; van Duijnhoven FH; van Seijen M; Bhairosing PA; Pinto D; Collyar D; Sawyer E; Hwang SE; Thompson AM; Wesseling J; Lips EH; Schmidt MK; Breast; 2020 Apr; 50():95-103. PubMed ID: 32120064 [TBL] [Abstract][Full Text] [Related]